Literature DB >> 27933639

Assessment of left atrial volume and function by real time three-dimensional echocardiography in obese patients.

Julide Yagmur1, Mehmet Cansel1, Ertugrul Kurtoglu2, Siho Hidayet2, Nusret Acıkgoz1, Necip Ermis1, Fatma Ozyalin3.   

Abstract

OBJECTIVE: To evaluate left atrial (LA) volume and functions in obese subjects using real time three-dimensional echocardiography (RT3DE) and also the relationship between LA mechanical functions and N-terminal pro-atrial natriuretic peptide (NT-proANP).
METHODS: This study included 40 obese (26 females and 14 males, mean age 51.9 years) and 40 normal weight subjects (23 females and 16 males, mean age 53.5 years) with normal coronary angiograms. All the study participants underwent RT3DE to assess LA volume and mechanical function. Plasma NT-proANP was determined by ELISA method.
RESULTS: There was no significant difference between groups in left ventricular (LV) diameters and ejection fraction, which reflect LV systolic function. However, transmitral deceleration time, isovolumetric relaxation time, and peak late diastolic tissue Doppler velocity values, which reflect LV diastolic function, were found to be significantly higher in obese subjects when compared with controls. LA maximum volume (LAVmax), LAVmax index (LAVI), LA minimal volume (LAVmin), before atrial contraction volume (LAVpreA), LA active emptying volume, LA total emptying volume, and LA active emptying fraction, which reflect LA reservoir and pump functions, were also higher in obese subjects when compared with controls. LA passive emptying fraction was significantly lower in obese subjects than in controls. NT-proANP levels were similar between groups. There were positive correlations between NT-proANP level and LAVI, LAVmax, LAVmin, LAVpreA, and LA total and active emptying volumes.
CONCLUSIONS: Left atrial mechanical functions and volumes are impaired in obese subjects. These findings may be regarded as early markers of subclinical cardiac failure in obese subjects who have not yet exhibited any clinical evidence of cardiovascular disease.
© 2016, Wiley Periodicals, Inc.

Entities:  

Keywords:  echocardiography; left atrial volume; obesity

Mesh:

Substances:

Year:  2016        PMID: 27933639     DOI: 10.1111/echo.13417

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

Review 1.  Obesity and heart failure with preserved ejection fraction: a paradox or something else?

Authors:  Marijana Tadic; Cesare Cuspidi
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

Review 2.  The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism.

Authors:  Yukang Mao; Kun Zhao; Peng Li; Yanhui Sheng
Journal:  Mol Cell Biochem       Date:  2022-10-10       Impact factor: 3.842

Review 3.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

Review 4.  A Review of the Roles and Limitations of Noninvasive Imaging Methods for Investigating Cardiovascular Disease in Individuals with Obesity.

Authors:  Rosana Marssaro Cortez; Marina Politi Okoshi; Katashi Okoshi
Journal:  Med Sci Monit       Date:  2022-07-30

5.  Mid-regional plasma pro-atrial natriuretic peptide and stroke volume responsiveness for detecting deviations in central blood volume following major abdominal surgery.

Authors:  Rune B Strandby; Niels H Secher; Rikard Ambrus; Jens P Gøtze; Amalie Henriksen; Carl C Kitchen; Michael P Achiam; Lars B Svendsen
Journal:  Acta Anaesthesiol Scand       Date:  2022-09-07       Impact factor: 2.274

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.